VanEck Associates’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-20,002
Closed -$1.6M 1329
2021
Q1
$1.6M Buy
20,002
+2,244
+13% +$179K ﹤0.01% 658
2020
Q4
$1.4M Sell
17,758
-8,024
-31% -$633K ﹤0.01% 605
2020
Q3
$1.13M Sell
25,782
-1,616
-6% -$71K ﹤0.01% 615
2020
Q2
$1.21M Sell
27,398
-12,003
-30% -$531K ﹤0.01% 583
2020
Q1
$1.41M Buy
39,401
+23,111
+142% +$829K 0.01% 511
2019
Q4
$1.16M Buy
16,290
+885
+6% +$62.7K ﹤0.01% 615
2019
Q3
$1.15M Sell
15,405
-1,023
-6% -$76.5K 0.01% 574
2019
Q2
$1.33M Buy
16,428
+213
+1% +$17.2K 0.01% 536
2019
Q1
$1.09M Buy
16,215
+5,336
+49% +$357K 0.01% 563
2018
Q4
$810K Buy
10,879
+1,938
+22% +$144K ﹤0.01% 568
2018
Q3
$823K Buy
8,941
+363
+4% +$33.4K ﹤0.01% 604
2018
Q2
$844K Buy
8,578
+1,195
+16% +$118K ﹤0.01% 584
2018
Q1
$823K Buy
7,383
+1,261
+21% +$141K ﹤0.01% 486
2017
Q4
$630K Sell
6,122
-888
-13% -$91.4K ﹤0.01% 532
2017
Q3
$660K Sell
7,010
-2,855
-29% -$269K ﹤0.01% 530
2017
Q2
$769K Buy
9,865
+96
+1% +$7.48K ﹤0.01% 509
2017
Q1
$782K Buy
9,769
+508
+5% +$40.7K ﹤0.01% 525
2016
Q4
$729K Buy
9,261
+1,028
+12% +$80.9K ﹤0.01% 520
2016
Q3
$642K Sell
8,233
-1,733
-17% -$135K ﹤0.01% 548
2016
Q2
$685K Buy
9,966
+1,204
+14% +$82.8K ﹤0.01% 513
2016
Q1
$625K Sell
8,762
-125
-1% -$8.92K ﹤0.01% 504
2015
Q4
$552K Sell
8,887
-1,178
-12% -$73.2K ﹤0.01% 463
2015
Q3
$571K Sell
10,065
-740
-7% -$42K ﹤0.01% 447
2015
Q2
$580K Sell
10,805
-1,204
-10% -$64.6K ﹤0.01% 471
2015
Q1
$570K Buy
12,009
+407
+4% +$19.3K ﹤0.01% 483
2014
Q4
$502K Sell
11,602
-1,432
-11% -$62K ﹤0.01% 480
2014
Q3
$448K Sell
13,034
-1,406
-10% -$48.3K ﹤0.01% 510
2014
Q2
$529K Buy
14,440
+477
+3% +$17.5K ﹤0.01% 483
2014
Q1
$471K Sell
13,963
-171
-1% -$5.77K ﹤0.01% 476
2013
Q4
$479K Sell
14,134
-3,724
-21% -$126K ﹤0.01% 457
2013
Q3
$569K Sell
17,858
-4,219
-19% -$134K ﹤0.01% 420
2013
Q2
$498K Buy
+22,077
New +$498K ﹤0.01% 424